The forecasts regarding the application of artificial intelligence (AI) in medicine are very optimistic. The forecast is that the size of the market will rise to 11.5 billion euros this year. And the figure will supposedly climb to 36.5 billion in 2029, which would entail an increase of more than 25% annually.
Analysts explain this evolution by the lifestyles that citizens maintain – with less time available for travel, but greater technological mastery – and the growing prevalence of chronic diseases. Regarding this second factor, the American Heart Association reports that the rate of heart failure in the country will reach six million patients, almost 2% of the population.
Experts from companies and institutions such as Siemens, KPMG, Verizon, Hans(wo)menGroup and Stanford University participated in the 2024 edition of the Mobile World Congress (MWC) in Barcelona to address these issues and many others. Initiatives such as the one developed by Dartmouth’s Geisel School of Medicine and its Cancer Center combine precision in data management and respect for ethical standards.
Professionals, both in healthcare and in IT, engineering and finance, are convinced that the confluence of technologies such as AI, machine learning and the Internet of Things is shaping a business model in which the person will be at the center of all actions.
In this regard, the most critical voices are surprised by the fact that work has not always been done this way. Be that as it may, in this new formula multiple facets are contemplated: from user service to administrative procedures, through the relationship with suppliers, pharmaceutical companies and a long etcetera.
The shortage of doctors in many nations is increasingly alarming. Representatives of the group that brings together the North American faculties of this specialty estimate that in just a decade between 37,800 and 124,000 doctors will be needed in the main power on the planet. At this point, one of the great opportunities for AI emerges.
